Ronald Herbst

Summary

Affiliation: MedImmune Vaccines
Country: USA

Publications

  1. pmc B-cell targeted therapeutics in clinical development
    Stephan Blüml
    MedImmune, LLC, Department of Research, One MedImmune Way, Gaithersburg, MD 20854, USA
    Arthritis Res Ther 15:S4. 2013
  2. doi request reprint CD19 and CD32b differentially regulate human B cell responsiveness
    Jodi L Karnell
    Respiratory, Inflammation, and Autoimmunity Group, MedImmune, LLC, Gaithersburg, MD 20878
    J Immunol 192:1480-90. 2014
  3. doi request reprint The plasma cell signature in autoimmune disease
    Katie Streicher
    MedImmune, Gaithersburg, Maryland
    Arthritis Rheumatol 66:173-84. 2014

Collaborators

  • Stephan Blüml
  • Yihong Yao
  • Nazzareno Dimasi
  • Katie Streicher
  • Jodi L Karnell
  • Fernanda Pilataxi
  • Bhargavi Rajan
  • Bahija Jallal
  • David Fiorentino
  • Ryan Fleming
  • Brandon W Higgs
  • LAURA K RICHMAN
  • Koustubh Ranade
  • Steven A Greenberg
  • Christopher A Morehouse
  • Christopher J Groves
  • Ellen Kuta
  • Kim P Lehmann
  • Rachel Ettinger
  • Kathleen McKeever
  • Mildred Wilson
  • Philip Z Brohawn
  • Fredrick G Karnell
  • Herren Wu
  • Changshou Gao

Detail Information

Publications3

  1. pmc B-cell targeted therapeutics in clinical development
    Stephan Blüml
    MedImmune, LLC, Department of Research, One MedImmune Way, Gaithersburg, MD 20854, USA
    Arthritis Res Ther 15:S4. 2013
    ....
  2. doi request reprint CD19 and CD32b differentially regulate human B cell responsiveness
    Jodi L Karnell
    Respiratory, Inflammation, and Autoimmunity Group, MedImmune, LLC, Gaithersburg, MD 20878
    J Immunol 192:1480-90. 2014
    ..Therefore, simultaneous targeting of multiple surface molecules may be a necessary approach to comprehensively modulate B cell activation in vivo. ..
  3. doi request reprint The plasma cell signature in autoimmune disease
    Katie Streicher
    MedImmune, Gaithersburg, Maryland
    Arthritis Rheumatol 66:173-84. 2014
    ..We undertook this study to investigate the prevalence of PCs and their relationship to known pathogenic pathways to increase our understanding of the role of PCs in disease progression and treatment response...